In December 2019, an unknown pneumonia-like disease appeared in Wuhan, China, but rapidly spread across the globe, prompting the World Health Organization (WHO) to label it as Coronavirus Disease 2019 (COVID-19) [1]. On 30 January 2020, the WHO declared a Public Health Emergency of International Concern (PHEIC) followed by pandemic declaration on 11 March 2020 [2]. In Bangladesh, the first case of COVID-19 infection was detected on 8 March, resulting in closure of educational institutions on 16 March. Following the first death on 18 March, in an attempt to contain the spread of the disease, the government of Bangladesh (GoB) declared a ‘general holiday’ from 26 March to 4 April, which was repeatedly extended until 9 April, 14 April, 25 April, 5 May, 16 May, and 30 May. Despite these measures, COVID-19 infections continued to increase, but lockdown (which was formally termed by the government as ‘general holidays) was withdrawn on 31 May [3]. The number of confirmed COVID-19 cases in Bangladesh exceeded 100,000 on 18 June, and the upward trend continued throughout summer, with 200,000 cases recorded on 18 July, 300,000 on 26 August, and 400,000 on 27 October [4]. By November 2020, Bangladesh ranked 24th and 20th in the world with respect to the total number of cases and deaths, respectively. At one point, Bangladesh ranked 3rd in terms of the number of new cases per day, but given that the country’s test rate (15,863 per million inhabitants) is among the lowest in the world (it is the second-lowest after Afghanistan among its South Asian neighbors) these figures are likely to be much higher [5].
Pandemic response in Bangladesh is guided by the Infectious Diseases (Prevention, Control, and Elimination) Act 2018, which places the Directorate General of Health Services (DGHS) as the central coordinating and responsible body for COVID-19 response. Institution of Epidemiology, Disease Control, and Research (IEDCR) is the main scientific body to provide technical guidance and support for screening at the point of entry, and is in charge of imposing quarantine, managing contact tracing, and conducting initial testing (which is later contracted out to other government and a few private laboratories), while also providing forecasting and surveillance services, and the overall outbreak response [6]. This agency was highly criticized for monopolizing all the COVID-19 tests in the first three weeks following the detection of the first case in a country of 180 million inhabitants. It was also blamed by the medical community for severe shortages of personal protective equipment (PPE) and tests, due to which many health professionals refused to provide care to infected individuals [7]. To address this issue, from 3 April, approvals for additional test facilities were gradually issued, initially in the public and later in private facilities, totaling to 117 on 18 November [8]. However, even though GenXpert equipment was already available for tuberculosis test, this antigen-based rapid test was only made available for COVID-19 test by the government in July 2020 [9]. Major events related to COVID-19 pandemic in Bangladesh are shown in Fig. 1.
Figure 1. COVID-19 Timeline in Bangladesh
Since the COVID-19 outbreak, the GoB has taken various measures to inform the public of the situation and restrict the transmission of the infection. However, available evidence indicates that success of such measures largely depends on a positive public perception of government’s ability to manage pandemics effectively, as well as foster multi-stakeholder cooperation [10], garner social order within the population [10, 11] and ensure good governance [12, 13]. In this context, timely and transparent communication is essential [14, 15], as is involvement of technical and health experts in decision-making [10, 16]. Gathering and sharing information on newly infected individuals and their contacts (as a part of contact tracing activities) is an important pandemic response activity, which can only be effective if general public trusts the relevant agencies and service providers [10, 14, 16]. When people have a positive perception of the health system, they are more likely to adhere to any measures imposed to protect public health [11, 16, 17]. Thus, COVID-19 response requires adaptive leadership capable of making bold decisions and passing timely regulations based on the most recent scientific evidence, which is impossible without a positive perception of or trust on decision-makers and all pertinent stakeholders, including general public [18].
Although the epidemiologic features of SARS-COV-2 virus [19, 20], its clinical manifestations in different patient groups [21, 22], and its molecular characteristics [23–25], as well as health systems response [26], economic and social consequences [27–29], and public attitudes toward the measures implemented in Bangladesh have been investigated [30–32], public perceptions of pandemic management efforts by the responsible bodies have never been studied. Motivated by the work of Bigdeli et al., we decided to explore the public perceptions of COVID-19 pandemic management in Bangladesh by focusing on the relationships between (1) people and the decision-makers (or the larger health system governance), (2) people and the service providers (only physicians were covered in this study), and (3) service providers and decision-makers [33]. Findings yielded by this qualitative study will help the decision-makers in introducing new or revising existing measures to allow service providers to better respond to the pandemic and increase public trust in the health system.